Vanta Bioscience IPO vs Worth Peripherals IPO

Comparision between Vanta Bioscience IPO and Worth Peripherals IPO.

IPO Details

Vanta Bioscience IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Worth Peripherals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Vanta Bioscience IPO	Worth Peripherals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Inventure Merchant Banker Services Pvt Ltd	Pantomath Capital Advisors Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Bigshare Services Pvt Ltd
Market Maker
DRHP	DRHP	DRHP
RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Vanta Bioscience IPO is up to ₹7.56 Cr whereas the issue size of the Worth Peripherals IPO is up to ₹18.28 Cr. The final issue price of Vanta Bioscience IPO is ₹50.00 per share and of Worth Peripherals IPO is ₹43.00 per share.

	Vanta Bioscience IPO	Worth Peripherals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹40.00 per share
Issue Price (Upper)		₹43.00 per share
Issue Price (Final)	₹50.00 per share	₹43.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	3000 shares	3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	15,12,000 shares	42,51,000 shares
Issue Size Total (Amount)	up to ₹7.56 Cr	up to ₹18.28 Cr

IPO Timetable

Vanta Bioscience IPO opens on Sep 25, 2017, while Worth Peripherals IPO opens on Sep 15, 2017. The closing date of Vanta Bioscience IPO and Worth Peripherals IPO is Sep 27, 2017, and Sep 19, 2017, respectively.

	Vanta Bioscience IPO	Worth Peripherals IPO
Anchor Bid Date
Issue Open	Sep 25, 2017	Sep 15, 2017
Issue Close	Sep 27, 2017	Sep 19, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Vanta Bioscience IPO P/E ratio is , as compared to Worth Peripherals IPO P/E ratio of .

Vanta Bioscience IPO

Worth Peripherals IPO

Financial

Summary of financial Information (Consolidated)
Particulars	For the year/period ended (in Rs. Lakhs)
	31-Mar-17	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13
Total Assets	8124.79	8571.20	6154.24	5449.23	4477.35
Total Revenue	13214.73	12740.00	10778.41	8423.23	5935.17
Profit After Tax	731.65	646.62	601.63	515.04	345.76

Promoter Shareholding (Pre-Issue)

Promoter Shareholding (Post-Issue)

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Vanta Bioscience IPO retail investors (RII) are offered while in Worth Peripherals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Vanta Bioscience IPO and 0 shares in Worth Peripherals IPO.

	Vanta Bioscience IPO	Worth Peripherals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB		0 shares
NII		21,25,500 shares
RII		21,25,500 shares
Employee
Others
Total		42,51,000 shares

Bids Received (Subscription)

Vanta Bioscience IPO subscribed in total, whereas Worth Peripherals IPO subscribed 2.62x.

	Vanta Bioscience IPO	Worth Peripherals IPO
QIB (times)
NII (times)		1.77x
Big NII (times)
Small NII (times)
RII (times)		3.25x
Employee (times)
Other (times)
Total (times)		2.62x

Compare with others

Vanta Bioscience IPO	Worth Peripherals IPO
Cadsys India IPO	Vanta Bioscience IPO
Innovative Tyres IPO	D P Wires IPO
Trident Texofab IPO	Shree Tirupati IPO
AKM Lace IPO	R M Drip IPO
Madhya Pradesh Today IPO	Sri Krishna Metcom IPO
D P Wires IPO	Sagar Diamonds IPO
Shree Tirupati IPO	Nouritrans Exim IPO
R M Drip IPO	Dhruv Wellness IPO
Sri Krishna Metcom IPO	A M Febcon
Worth Peripherals IPO	Manav infra projects IPO

Comments

Add a public comment...